Combining glucagon-like peptide 1 analogues with sodium-glucose cotransporter 2 inhibitors to treat patients with type 1 diabetes, BMI > 25 kg/m2, and chronic kidney disease – A randomised, controlled pilot study

In patients with type 1 diabetes, BMI > 25 kg/m<sup>2</sup>, and chronic kidney disease, the combining GLP-1 + SGLT2i + lifestyle modification was safe and produced significant weight loss but did not significantly improve metabolic and blood pressure control.

Institutions

Publication Details

Journal
Diabetes Research and Clinical Practice
Published
2025-12-21
DOI
https://doi.org/10.1016/j.diabres.2025.113066
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
1.29

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combining glucagon-like peptide 1 analogues with sodium-glucose cotransporter 2 inhibitors to treat patients with type 1 diabetes, BMI > 25 kg/m2, and chronic kidney disease – A randomised, controlled pilot study

1 citations
Diabetes Research and Clinical Practice
Diabetes Treatment and Management
1.29
article

Combining glucagon-like peptide 1 analogues with sodium-glucose cotransporter 2 inhibitors to treat patients with type 1 diabetes, BMI > 25 kg/m2, and chronic kidney disease – A randomised, controlled pilot study

article en
1 citations

Abstract

In patients with type 1 diabetes, BMI > 25 kg/m<sup>2</sup>, and chronic kidney disease, the combining GLP-1 + SGLT2i + lifestyle modification was safe and produced significant weight loss but did not significantly improve metabolic and blood pressure control.

Diabetes Research and Clinical PracticeVol. 231
University College Dublin (IE), Princess Nourah bint Abdulrahman University (SA), University of Ulster (GB), Amiri Hospital (KW), Dasman Diabetes Institute (KW), Imperial College London (GB)
European Federation of Pharmaceutical Industries and Associations, European Commission, Princess Nourah Bint Abdulrahman University, Dasman Diabetes Institute
Openalex Percentile: Top 13%
Diabetes Treatment and Management
1.29
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.